Earnings NewsHealthcareIntercept Pharma Q4 2021 Earnings PreviewMar. 01, 2022 11:59 AM ETIntercept Pharmaceuticals, Inc. (ICPT)By: Jessica Kuruthukulangara, SA News Editor Intercept Pharma (NASDAQ:ICPT) is scheduled to announce Q4 earnings results on Wednesday, Mar. 2, before market open. The consensus EPS estimate is -$0.81 and the consensus revenue estimate is $92.09M (+10.7% Y/Y). Over the last 1 year, ICPT has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time. SA contributor Biotech Enthusiast recently wrote "Intercept Might Be An Intriguing Turn-Around Story", rating the stock Buy. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.